P3 Health Partners Inc. (NASDAQ: PIII), a healthcare company focused on patient-centered and physician-led population health management, has recently announced its financial results for the third quarter of 2024, ending on September 30. This announcement is significant news for health partners and the broader healthcare industry as it provides insights into the financial health and strategic direction of a key player in value-based care.
Aric Coffman, CEO of P3 Health Partners, stated that the company is actively executing strategic initiatives aimed at leveraging the value within their platform to achieve sustainable and profitable growth in the long run. He acknowledged that while short-term dynamics have negatively impacted recent financial results, the underlying demand for P3’s platform remains strong. Coffman emphasized the company’s continued commitment to delivering value to patients, payers, and their primary care physician (PCP) partners, highlighting the fundamental strength of their business model, evidenced by member and revenue growth, positive quality outcomes, and strong provider retention rates. This perspective is crucial for understanding the current landscape of Health Partners News, where adaptability and strategic foresight are highly valued.
Third Quarter 2024 Financial Performance Overview
The financial results for the third quarter of 2024 reveal a mixed performance for P3 Health Partners. While the company demonstrated substantial revenue growth, profitability metrics experienced a significant downturn compared to the same period in the previous year. These results offer valuable health partners news, reflecting current trends and challenges within the healthcare management sector.
-
Revenue Growth: Total revenue reached $362.1 million, marking a 26% increase compared to $288.4 million in the third quarter of 2023. Capitated revenue, a key indicator of stable income from at-risk members, also saw a 25% increase, reaching $357.7 million from $285.2 million in the prior year’s quarter. This growth in revenue is a positive sign, indicating an expanding operational scale and market presence for P3 Health Partners within the network of health partners.
-
Gross Profit Decline: Despite revenue growth, gross profit presented a loss of $39.8 million, a stark contrast to the $9.1 million gross profit in the third quarter of the previous year. Gross profit per member per month (PMPM) also declined to a loss of $103, compared to a profit of $29 PMPM in the same period last year. This shift in gross profit is critical health partners news, suggesting rising costs associated with service delivery or changes in revenue realization.
-
Medical Margin Reduction: Medical margin, a crucial metric reflecting the profitability of healthcare service delivery, was significantly reduced to $0.5 million, down from $36.2 million in the prior year. Medical margin PMPM decreased to $1, compared to $115 PMPM in the third quarter of 2023. This substantial decrease in medical margin is important health partners news, indicating potential pressures in managing medical expenses or changes in reimbursement rates.
-
Net Loss Expansion: The net loss for the quarter amounted to $102.9 million, considerably higher than the $37.3 million net loss in the third quarter of the previous year. Net loss PMPM also increased to $267, compared to $119 PMPM in the same quarter of 2023. The expansion of net loss is a significant piece of health partners news, signaling increased overall financial strain on the company during this period.
-
Adjusted EBITDA Loss Increase: Adjusted EBITDA loss, a non-GAAP measure often used to evaluate operational performance, was $71.0 million, compared to $22.3 million in the third quarter of the previous year. Adjusted EBITDA loss PMPM worsened to $184, from $71 PMPM in the comparable prior year quarter. This increase in Adjusted EBITDA loss is relevant health partners news, reflecting challenges in operational efficiency and cost management.
-
Guidance Withdrawal: In light of lower-than-expected 2024 risk adjustments, persistent high medical costs, and retroactive adjustments, P3 Health Partners has withdrawn its financial guidance for the fiscal year ending December 31, 2024. This withdrawal, initially provided on August 7, 2024, indicates considerable uncertainty in the company’s financial forecasting and is noteworthy health partners news for investors and stakeholders.
Conference Call and Webcast Details
P3 Health Partners hosted a conference call and live webcast on November 12, 2024, at 4:30 PM Eastern Time to discuss these third-quarter results. This event is a key source of health partners news, offering deeper insights into the company’s performance and future strategies.
For those interested in accessing further details, an archived recording of the webcast is available on the investor relations section of the P3 Health Partners website (ir.p3hp.org) for 90 days following the call. This accessibility ensures that stakeholders and those tracking health partners news can stay informed.
About P3 Health Partners Inc.
P3 Health Partners Inc. is dedicated to transforming healthcare through enhanced patient care and provider support. As a physician-founded and led company, P3 operates an extensive network of over 3,100 affiliated primary care providers across the United States. Their healthcare professionals deliver coordinated care to thousands of patients across 27 counties in five states. P3’s model focuses on value-based care coordination and administrative services, aiming to improve patient outcomes while reducing healthcare costs. Through collaborative partnerships with local providers, P3 enhances patient experience by effectively navigating and integrating patient care within the broader healthcare ecosystem. This approach positions P3 Health Partners as a significant entity in health partners news, driving innovation and patient-centric models.
For more detailed information about P3 Health Partners, please visit their website at www.p3hp.org. Regular updates and insights can also be found by following their social media channels @p3healthpartners on Instagram and Facebook.com/p3healthpartners on Facebook, offering continuous health partners news and company developments.
Non-GAAP Financial Measures
In their financial reporting, P3 Health Partners utilizes certain non-GAAP financial measures, including Adjusted EBITDA and medical margin, to provide additional perspectives on their operational performance. These measures are adjusted from standard GAAP calculations to exclude specific items, offering a view that management believes is more reflective of the company’s core operating performance. Adjusted EBITDA, for example, is derived from net income (loss) by excluding interest, taxes, depreciation, amortization, and other supplemental adjustments like mark-to-market warrant gains/losses, premium deficiency reserves, equity-based compensation, and certain transaction-related costs. Medical margin is calculated as capitation revenue minus medical claims expenses. These non-GAAP measures are intended to help investors better evaluate the company’s ongoing results and compare them against industry peers, making them relevant for health partners news analysis. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are provided in the financial tables of their press release.
Forward-Looking Statements
It is important to note that this announcement contains forward-looking statements, which are subject to various risks and uncertainties as detailed in the company’s filings with the Securities and Exchange Commission. These statements are based on current expectations and available data, and actual results may differ materially due to factors beyond the company’s control. P3 Health Partners advises readers not to place undue reliance on these forward-looking statements, which are not guarantees of future performance and are relevant only as of the date of the announcement. This cautionary note is a standard component of health partners news related to financial disclosures, ensuring informed investment decisions.
Financial Tables Summary
The detailed financial results, including Condensed Consolidated Balance Sheets, Statements of Operations, and Statements of Cash Flows, along with reconciliations of non-GAAP measures, are provided in the original press release. These tables offer an in-depth look at P3 Health Partners’ financial position and performance for the reported periods, crucial for stakeholders following health partners news and financial health. Key metrics such as cash assets, receivables, liabilities, and equity are outlined in the balance sheets. Revenue, expenses, and net loss are detailed in the statements of operations. Cash flow activities from operations, investing, and financing are presented in the cash flow statements. These financial tables are essential for a comprehensive understanding of P3 Health Partners’ Q3 2024 financial health and are integral to health partners news for financial analysts and investors.
Contact Information
For further inquiries, investors and media can reach out to:
Ryan Halsted
Investor Relations
Gilmartin Group
[email protected]
This contact information ensures that interested parties have a direct channel for follow-up questions regarding this health partners news release.
